Artificial intelligence (AI) offers a new path forward for clinical trial sponsors, contract research organizations (CROs), and research sites collaborating on trials. By replacing reactive protocols ...

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD.

The genetic roots of a disease or disorder do not always grow into clear-cut, easily diagnosed clinical features. Even if a ...

AbCellera Biologics eyes long-term growth with a new facility, clinical trial progress, and a pivot to proprietary drug ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...

The treatment of patients with pain and co-occurring disorders presents a significant knowledge gap that necessitates a ...

Special Report: Melbourne-headquartered Trajan’s Disruptive Technologies segment is at the forefront of a global move toward ...

Dr Sarah Premji discusses advancements in breast cancer treatment, emphasizing community trials, personalized therapies, and ...

Freeze-drying is preferred for sensitive samples because it combines low-temperature processing with gentle water removal.

Redundancy isn't just a problem in health IT, it's the status quo. Overlapping systems and bloated tech stacks make it difficult for healthcare leaders ...